Article

Clinical Knowledge Key to Advancing Orthobiologics Technologies

13 Apr 2018

DSM Biomedical is developing 'disruptive' innovation with advanced physical and biologic properties to better meet market needs.

David Yonce, vice president of Innovation and R&D at DSM Biomedical was among the experts interviewed for the feature; his full input is provided in the following Q&A.

Michael Barbella, Managing Editor
Published: Orthopedic Design Technology Magazine

Read the full article

Related content

  • Orthopedics

    DSM Biomedical materials and technologies support orthopedic applications, including spine, trauma and sports medicine. Learn more.

Read more

  • Our products

    DSM portfolio of innovative biomedical materials and process manufacturing technologies: Biomedical Polyethylenes, Biomedical polyurethanes, Collagen Technology, Device Development, and Extracellular Matrix (ECM) Technology. Learn more.

  • The markets we serve

    DSM Biomedical offers the broadest portfolio of biomedical materials and manufacturing across market applications, including orthopedics, ophthalmology, neurology, cardiology, diabetes, wound, and continence care.

This site uses cookies to store information on your computer.

Learn more